85798-11-4

Upstream product

• 85716-44-5 methyl 2,3,4-tri-O-benzyl-α-d-xylo-hex-5-enopyranoside 
• 606930-14-7 (2S,3R,4S)-2,3,4-tris-benzyloxy-5-hydroxycyclohexan-1-one 
• 116386-41-5 (3S,4S,5R,6S)-4,5-Bis-benzyloxy-6-methoxy-2-methylene-tetrahydro-pyran-3-ol 
• 87326-88-3 methyl 6-deoxy-6-iodo-2,3-bis-O-(phenylmethyl)-α-D-glucopyranoside 
• 4356-80-3 methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 73111-13-4 Methanesulfonic acid (2R,3R,4S,5R,6S)-3,4,5-tris-benzyloxy-6-methoxy-tetrahydro-pyran-2-ylmethyl ester 
• 100-39-0 benzyl bromide 
• 4144-87-0 methyl 6-chloro-6-deoxy-α-D-glucopyranoside 
• 18311-26-7 methyl 6-O-trityl-α-D-glucopyranoside 
• 97-30-3 methyl-alpha-D-glucopyranoside 
• 85716-43-4 methyl 6-deoxy-6-iodo-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 53008-65-4 methyl 2,3,4-tri-O-benzyl-D-glucopyranoside 
• 2595-06-4 methyl 2,3,4-tri-O-benzyl-6-O-trityl-α-D-glucopyranoside 
• 6304-96-7 methyl 2,3,4-tri-O-acetyl-6-deoxy-6-iodo-α-D-glucopyranoside 

Downstream Products

• 106988-91-4 1L-(1,2,4/3)-2,3,4-tri-O-benzyl-1-C-(5-methyl-1,3,5-dithiazinan-2-yl)-5-cyclohexen-1,2,3,4-tetrol 
• 107079-33-4 1D-(2,4/1,3)-1,2,3-tri-O-benzyl-4-C-(5-methyl-1,3,5-dithiazinan-2-yl)-5-cyclohexen-1,2,3,4-tetrol 
• 128500-12-9 1D-(1,3/2,4)-1-O-acetyl-1-benzyloxymethyl-2,3,4-tri-O-benzyltetrahydroxycyclohex-5-ene 
• 103066-43-9 (3S,4R,5R)-tribenzyloxy-(6R)-hydroxycyclohexene 
• 102997-58-0 (1R,2R,3S)-tris(phenylmethoxy)-6S-hydroxy-cyclohex-4-ene 
• 223524-30-9 (1S,4S,5R,6S)-4,5,6-Tris-benzyloxy-cyclohex-2-enol 
• 102997-56-8 1R(1,2,4/3,5)-1,2-anhydro-3,4,5-tri-O-benzyl-6-enecyclohexane-1,2,3,4,5-pentol 
• 85716-46-7 1D-(1,3/2)-1,2,3-tri-O-benzyl-4-methylene-5-cyclohexen-1,2,3-triol 
• 6195-80-8 2,4-bis(benzyloxy)phenol 
• 947329-39-7 (3S,4S,5R,6S)-4,5,6-tris-benzyloxy-1-(tert-butyldimethylsilyloxy)-3-methoxycarbonylmethylcyclohex-1-ene 
• 1313193-67-7 C₂₁H₂₀O₄ 
• 1187828-00-7 (4S,5R,6S)-4,5,6-tris(benzyloxy)-2-methylcyclohex-2-enone 
• 1313193-64-4 (4S,5R,6S)-4,5,6-tris(benzyloxy)-2-iodocyclohex-2-en-1-one 
• 1376712-19-4 (4S,5R,6S)-4,5,6-tris(benzyloxy)-2-(hydroxy(4-nitrophenyl)methyl)cyclohex-2-enone 

Relevant academic research and scientific papers

Syntheses of (-)-gabosine A, (+)-4-epi-gabosine A, (-)-gabosine E, and (+)-4-epi-gabosine e

(+)-4-epi-Gabosine A 1 and (-)-gabosine A 2 have been synthesized starting from methyl α,d-glucopyranoside and methyl α,d-mannopyranoside, respectively, by utilizing Pd(0) catalyzed Stille coupling as the key step. On the other hand, syntheses of (+)-4-ep

Transformation of glucose into a novel carbasugar amino acid dipeptide isostere

The synthesis of a novel carbasugar amino acid (15), starting from D-glucose and using the Ferrier rearrangement as a key step, is reported. Compound 15 is implemented as dipeptide isostere in the synthesis of a Leu-enkephalin analog. Copyright Taylor & F

Synthesis of cyclophellitol utilizing a palladium chloride mediated-ferrier-II rearrangement

Cyclophellitol and its C3-epimer have been synthesized from 5-enoglucopyranoside and 5-enomannopyranoside, respectively. The carbocyclic skeleton was constructed through a Ferrier-II reaction meditated by PdCl 2.

An efficient synthesis of cyclophellitol utilizing unusual regioselectivity of oxirane ring opening with Mes2BCH2Li

Cyclophellitol has been synthesized from 5,6-enoglucoside efficiently. The carbacyclic skeleton was constructed through a Ferrier reaction mediated by PdCl2. The regioselectivity on the oxirane ring opening with Mes2BCH2Li

β-acarbose. I. The synthesis of 1-epivalienamine

Improvements and modifications to a literature procedure for the synthesis of multigram amounts of a derivative of 1-epivalienamine are described. As well, various other derivatives of 1-epivalienamine, of potential use in the synthesis of carba sugars, a

An effective strategy for the synthesis of 6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-D-chiro- and -D-myo-inositol 1-phosphate related to putative insulin mimetics

Two glycosylinositol phosphates related to putative insulin mimetics, 6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-D-chiro-inositol 1-phosphate (1) and 6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-D-myo-inositol 1-phosphate (2), have been synthesized from selectively protected and enantiomerically pure D-chiro- and myo-inositol derivatives. The D-chiro-inositol unit was prepared in a multigram scale from D-glucose using the Ferrier's carbocyclization route, and it was transformed into the corresponding myo epimer by an oxidation-reduction sequence. The trichloroacetimidate method was applied efficiently for the key glycosylation of the inositol derivatives.

Synthesis of new aminocyclitols as potent enzymatic inhibitors

The syntheses of new pseudo-saccharides having an allylic amino moiety or an aziridine group are reported starting from methyl-α-D-glucopyranoside. To enhance the hydrophilic/lipophilic balance, pseudo-saccharides 9 and 10 were linked with a glycosyl deri

Synthesis of Branched-chain D-myo-Inositols using the Sigmatropic Claisen Rearrangement

A new and efficient synthesis of branched-chain cyclitols and their congeners utilizing a stereospecific Claisen rearrangement is reported.

α-Glucosidase Inhibitors, 5.- Investigations towards a Synthesis of C1-Branched Cyclitols from D-Glucose

The glucose derivatives 1 and 2 were transformed by Ferrier rearrangement as one of the reaction steps into the cyclitol derivatives 3a,b and 4a,b, respectively.The attachment of a functional C1-side chain at the carbonyl group was tested with